ADMA Biologics, Inc.
USD8.35
-0.03 (-0.30%)
CEO
Adam S. Grossman
IPO Date
2013-10-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.49
Prev. Close
$8.37
Day Low
$8.29
Day High
$8.53
52W Low
$7.21
52W High
$20.46
Market Cap
$1.93B
Volume
0.63M
| 20.2 |
| 31 Dec 2023 | FY | 34.4% | -10.9% | -20.9% | -8.6% | 1.05 | 5.16 | -35.9 |
| 31 Dec 2022 | FY | 22.9% | -42.8% | -43.4% | -18.9% | 1.02 | 6.89 | -11.6 |
| 31 Dec 2021 | FY | 1.4% | -88.5% | -50.8% | -25.9% | 0.73 | 6.87 | -2.7 |
| 31 Dec 2020 | FY | -45.2% | -179.4% | -85.8% | -36.5% | 1.11 | 7.71 | -2.2 |
| 31 Dec 2019 | FY | -34.6% | -164.5% | -184.3% | -38.0% | 3.23 | 6.12 | -4.5 |
| 31 Dec 2018 | FY | -148.4% | -387.1% | -332.5% | -74.0% | 2.24 | 4.63 | -1.6 |
| 31 Dec 2017 | FY | -28.1% | -192.3% | -108.5% | -40.5% | 1.07 | 6.69 | -1.7 |
| 31 Dec 2016 | FY | 40.3% | -183.1% | 437.8% | -82.4% | -4.55 | 1.93 | -3.2 |
| 22.0 |
| 30 Sept 2025 | Q3 | 56.3% | 27.1% | 8.4% | 6.4% | 0.19 | 7.13 | 24.0 |
| 30 Jun 2025 | Q2 | 55.1% | 28.1% | 8.6% | 6.1% | 0.21 | 5.33 | 32.1 |
| 31 Mar 2025 | Q1 | 53.2% | 23.4% | 7.2% | 5.3% | 0.22 | 6.58 | 43.8 |
| 31 Dec 2024 | Q4 | 53.9% | 95.2% | 32.1% | 22.9% | 0.24 | 5.97 | 9.1 |
| 30 Sept 2024 | Q3 | 49.8% | 30.0% | 15.5% | 9.2% | 0.48 | 7.09 | 32.6 |
| 30 Jun 2024 | Q2 | 53.6% | 29.9% | 17.0% | 8.5% | 0.75 | 6.87 | 20.9 |
| 31 Mar 2024 | Q1 | 47.8% | 21.7% | 11.6% | 5.1% | 0.92 | 5.21 | 21.0 |
| 31 Dec 2023 | Q4 | 42.1% | -23.9% | -13.1% | -5.4% | 1.05 | 5.16 | -14.5 |